These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33513979)

  • 1. Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours.
    Setargew YFI; Wyllie K; Grant RD; Chitty JL; Cox TR
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the lysyl oxidases in tumour desmoplasia.
    Chitty JL; Setargew YFI; Cox TR
    Biochem Soc Trans; 2019 Dec; 47(6):1661-1678. PubMed ID: 31754702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysyl Oxidase and the Tumor Microenvironment.
    Wang TH; Hsia SM; Shieh TM
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysyl oxidase, extracellular matrix remodeling and cancer metastasis.
    Xiao Q; Ge G
    Cancer Microenviron; 2012 Dec; 5(3):261-73. PubMed ID: 22528876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysyl Oxidase Mechanisms to Mediate Gastrointestinal Cancer Progression.
    Farhat A; Ferns GA; Ashrafi K; Arjmand MH
    Gastrointest Tumors; 2021 Jan; 8(1):33-40. PubMed ID: 34568293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients.
    Liu N; Cox TR; Cui W; Adell G; Holmlund B; Ping J; Jarlsfelt I; Erler JT; Sun XF
    Oncotarget; 2017 Sep; 8(36):60015-60024. PubMed ID: 28947950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links.
    Vallet SD; Ricard-Blum S
    Essays Biochem; 2019 Sep; 63(3):349-364. PubMed ID: 31488698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases.
    Perryman L; Gray SG
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Insights Into Lysyl Oxidases in Cartilage Regeneration and Rejuvenation.
    Lin W; Xu L; Li G
    Front Bioeng Biotechnol; 2020; 8():359. PubMed ID: 32426343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective expression of lysyl oxidase (LOX) in the stromal reactions of broncho-pulmonary carcinomas.
    Peyrol S; Galateau-Salle F; Raccurt M; Gleyzal C; Sommer P
    Histol Histopathol; 2000 Oct; 15(4):1127-35. PubMed ID: 11005237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer.
    Nilsson M; Adamo H; Bergh A; Halin Bergström S
    Sci Rep; 2016 Jan; 6():19608. PubMed ID: 26804196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the lysyl oxidase enzyme family in cardiac function and disease.
    Al-U'datt D; Allen BG; Nattel S
    Cardiovasc Res; 2019 Nov; 115(13):1820-1837. PubMed ID: 31504232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay Between LOX Enzymes and Integrins in the Tumor Microenvironment.
    Amendola PG; Reuten R; Erler JT
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31130685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts.
    Mižíková I; Palumbo F; Tábi T; Herold S; Vadász I; Mayer K; Seeger W; Morty RE
    Physiol Genomics; 2017 Aug; 49(8):416-429. PubMed ID: 28698228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysyl oxidase family members in urological tumorigenesis and fibrosis.
    Li T; Wu C; Gao L; Qin F; Wei Q; Yuan J
    Oncotarget; 2018 Apr; 9(28):20156-20164. PubMed ID: 29732010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction.
    González-Santamaría J; Villalba M; Busnadiego O; López-Olañeta MM; Sandoval P; Snabel J; López-Cabrera M; Erler JT; Hanemaaijer R; Lara-Pezzi E; Rodríguez-Pascual F
    Cardiovasc Res; 2016 Jan; 109(1):67-78. PubMed ID: 26260798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale for targeting the LOX family in cancer.
    Barker HE; Cox TR; Erler JT
    Nat Rev Cancer; 2012 Jul; 12(8):540-52. PubMed ID: 22810810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of lysyl oxidase as a potential predictive biomarker for oral squamous cell carcinoma: an immunohistochemical study.
    Bhanu U; Natarajan S; Manaktala N; Boaz K; Joshi R; Deepak S; Kp N; Lewis A
    Minerva Stomatol; 2020 Dec; 69(6):360-369. PubMed ID: 32744444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of enzymatically active human lysyl oxidase and lysyl oxidase-like protein from Escherichia coli inclusion bodies.
    Jung ST; Kim MS; Seo JY; Kim HC; Kim Y
    Protein Expr Purif; 2003 Oct; 31(2):240-6. PubMed ID: 14550642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential for targeting extracellular LOX proteins in human malignancy.
    Mayorca-Guiliani A; Erler JT
    Onco Targets Ther; 2013 Nov; 6():1729-35. PubMed ID: 24348049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.